These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18811897)

  • 41. The tortoise and the hare: slow and steady stem cells win the race.
    Dvorak CC
    Leuk Res; 2010 May; 34(5):572-3. PubMed ID: 19959228
    [No Abstract]   [Full Text] [Related]  

  • 42. Mobilization of peripheral blood stem cells for autologous transplantation. Methods, mechanisms, and role in accelerating hematopoietic recovery.
    Janssen WE
    Ann N Y Acad Sci; 1995 Dec; 770():116-29. PubMed ID: 8597354
    [No Abstract]   [Full Text] [Related]  

  • 43. Proceedings of the International Symposium on Peripheral Blood Stem Cell Autografts. 15-17 October, 1989, Mulhouse, France.
    Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():1-81. PubMed ID: 1969300
    [No Abstract]   [Full Text] [Related]  

  • 44. Relapse of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome without increased level of vascular endothelial growth factor following successful autologous peripheral blood stem cell transplantation.
    Imai N; Taguchi J; Yagi N; Konishi T; Serizawa M; Kobari M
    Neuromuscul Disord; 2009 May; 19(5):363-5. PubMed ID: 19269178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [High-dose autologous stem cell administration in malignant diseases--an established method, unclear indications].
    Brinch L; Evensen SA
    Tidsskr Nor Laegeforen; 1994 Nov; 114(28):3358. PubMed ID: 7809897
    [No Abstract]   [Full Text] [Related]  

  • 46. What's happening: an overview of potential adverse reactions associated with apheresis technology.
    Maurício R; de Sousa G; Seghatchian J
    Transfus Apher Sci; 2005 Nov; 33(3):351-6. PubMed ID: 16226918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma levels of FL and SDF-1 and expression of FLT-3 and CXCR4 on CD34+ cells assessed pre and post hematopoietic stem cell mobilization in patients with hematologic malignancies and in healthy donors.
    Cecyn KZ; Schimieguel DM; Kimura EY; Yamamoto M; Oliveira JS
    Transfus Apher Sci; 2009 Jun; 40(3):159-67. PubMed ID: 19380254
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Severe neurotoxicity associated with dimethyl sulphoxide following PBSCT.
    Abdelkefi A; Lakhal A; Moojat N; Hamed LB; Fekih J; Ladeb S; Torjman L; Othman TB
    Bone Marrow Transplant; 2009 Sep; 44(5):323-4. PubMed ID: 19234515
    [No Abstract]   [Full Text] [Related]  

  • 49. Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma.
    Yoon DH; Sohn BS; Jang G; Kim EK; Kang BW; Kim C; Kim JE; Kim S; Lee DH; Lee JS; Park SJ; Park CJ; Huh J; Suh C
    Transfusion; 2009 Sep; 49(9):1890-900. PubMed ID: 19453991
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiogenic potential of endothelial progenitor cells.
    Murasawa S; Asahara T
    Ther Adv Cardiovasc Dis; 2008 Oct; 2(5):341-8. PubMed ID: 19124432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical-grade purification of natural killer cells in haploidentical hematopoietic stem cell transplantation.
    Meyer-Monard S; Passweg J; Siegler U; Kalberer C; Koehl U; Rovó A; Halter J; Stern M; Heim D; Alois Gratwohl JR; Tichelli A
    Transfusion; 2009 Feb; 49(2):362-71. PubMed ID: 19389215
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors.
    Serefhanoglu S; Goker H; Buyukasik Y; Turgut M; Sayinalp N; Haznedaroglu IC; Aksu S; Akman U; Ozcebe OI
    Ann Hematol; 2009 Jul; 88(7):667-71. PubMed ID: 19082594
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can hematopoietic stem cells be an alternative source for skin regeneration?
    Fu X; Sun X
    Ageing Res Rev; 2009 Jul; 8(3):244-9. PubMed ID: 19491043
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perioperative apheresis.
    Potter PS
    Transfusion; 2004 Dec; 44(12 Suppl):54S-7S. PubMed ID: 15585006
    [No Abstract]   [Full Text] [Related]  

  • 55. Hematopoietic stem cell engraftment by early-stage in utero transplantation in a mouse model.
    Chen X; Gong XL; Katsumata M; Zeng YT; Huang SZ; Zeng F
    Exp Mol Pathol; 2009 Dec; 87(3):173-7. PubMed ID: 19666020
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New light on the biology and developmental potential of haematopoietic stem cells and progenitor cells.
    Sigvardsson M
    J Intern Med; 2009 Oct; 266(4):311-24. PubMed ID: 19765177
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transfusion medicine illustrated. Volume-reduced apheresis platelets.
    Smogorzewska A; Dzik W
    Transfusion; 2005 May; 45(5):651. PubMed ID: 15847649
    [No Abstract]   [Full Text] [Related]  

  • 58. The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation.
    Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Wang Y; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
    Pediatr Blood Cancer; 2009 Dec; 53(6):1100-6. PubMed ID: 19743519
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Physiopathology and possible clinical use of hematopoietic stem cells. Recent advances].
    Testa U
    Recenti Prog Med; 2009 Mar; 100(3):144-55. PubMed ID: 19475843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. With first successful allogeneic transplantations of apheresis-derived hematopoietic progenitor cells reported, can the recruitment of volunteer matched, unrelated stem cell donors be expanded substantially?
    Korbling M; Przepiorka D; Gajewski J; Champlin RE; Chan KW
    Blood; 1995 Aug; 86(3):1235. PubMed ID: 7620177
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.